Animal Model Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Animal Model Market Size, Value And Growth Trends Through 2030
The animal model market has undergone substantial expansion in recent times. Its value is projected to rise from $2.07 billion in 2025 to $2.24 billion in 2026, representing a compound annual growth rate (CAGR) of 8.5%. This historical growth has been driven by several factors, including a higher incidence of chronic diseases, a growing need for preclinical investigations, increased pharmaceutical research and development, advancements in laboratory technology, and the broadening of academic research facilities.
The animal model market is poised for substantial expansion in the coming years, projected to reach $2.97 billion by 2030 with a compound annual growth rate (CAGR) of 7.3%. This forecasted growth is driven by the integration of artificial intelligence and machine learning into preclinical studies, the advancement of precision medicine initiatives, the growing role of contract research organizations (CROs) and outsourcing, the proliferation of genetically modified animal models, and a heightened emphasis on translational research. Key developments shaping this period include the creation of sophisticated animal models, the use of genetically engineered variants, the application of high-throughput screening in preclinical work, the merging of imaging and diagnostic tools, and the increasing influence of contract research organizations.
Download A Free Sample Report For Comprehensive Market Insights:
#Animal Model Market Growth Factors: Which Forces Are Supporting Market Expansion?
The anticipated expansion of the animal model market is being fueled by increasing investments in pharmaceutical research and development (R&D). This R&D focuses on discovering, developing, and testing new therapies, which depend on extensive preclinical studies to assess safety, efficacy, and biological mechanisms before human trials can commence. The escalation in R&D spending is propelled by a rising demand for innovative treatments, a higher incidence of complex diseases, and ongoing scientific progress. Animal models serve as crucial components in this context by offering reliable preclinical platforms that closely simulate human physiology, thus facilitating predictive evaluations of drug performance. For example, as reported in November 2023 by the European Federation of Pharmaceutical Industries and Associations—a trade organization based in Belgium—pharmaceutical R&D expenditure increased to 50,000 million in 2023 from 47,010 million in 2022. Consequently, the growth in the animal model market is being driven by this uptick in pharmaceutical R&D spending.
Animal Model Market Segment Analysis Highlighting Growth Areas
The animal model market covered in this report is segmented –
1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations
Subsegments:
1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice
2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats
3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs
4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds
5) By Hamsters: Syrian Hamsters, Chinese Hamsters
6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)
Animal Model Market Industry Trends: What Changes Are Reshaping Demand?
Leading firms in the animal model space are prioritizing the creation of innovative offerings—particularly triple immune-deficient animal models—to improve the precision and dependability of preclinical trials, bolster advanced biomedical investigations, and accelerate the development of new treatments for intricate human disorders. These specially engineered animals, most often mice, are designed without three essential immune system elements. Their worth in biomedical research is substantial, especially for examining human diseases and crafting novel therapies. As an example, in January 2024, Charles River Laboratories International, Inc., a pharmaceutical company headquartered in the United States, introduced NCG mouse strains—a triple immune-deficient mouse model intended for oncology research. NCG mice are characterized by the absence of functional or mature T, B, and NK cells, along with diminished macrophage and dendritic cell activity. Such animal models are capable of supporting xenograft cells, tissues, and components of the human immune system. This mouse model is exceptionally well-suited for studies spanning oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplantation. Additionally, NCG mice can be used to generate humanized mice through the engraftment of PBMCs or CD34+ stem cells, effectively replicating the human immune system.
Animal Model Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.
Access The Complete Animal Model Market Report:
Animal Model Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the animal model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
